MDMA analogs (University of Western Australia/Emyria)

N/A

Report date: 2025/03/20 15:47:38
NME

Base Information

Drug NameMDMA analogs (University of Western Australia/Emyria)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStress Disorders, Post-TraumaticMental DisordersIntellectual Disability +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Western Australia
China Registration ClassN/A

Develop Information

Active CompaniesEmyria LimitedThe University Of Western Australia
Inactive CompaniesPsychoGenics Inc
Active IndicationsStress Disorders, Post-TraumaticIntellectual Disability
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A